Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-074380
Filing Date
2025-08-05
Accepted
2025-08-05 20:16:06
Documents
2
Period of Report
2025-08-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2522566-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2522566-1_4seq1.xml 4 6439
2 EXHIBIT 24 tm2522566d1_ex24.htm EX-24 8430
  Complete submission text file 0001104659-25-074380.txt   16305
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Issuer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERONA PHARMA PLC 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address
Ullman Anders (Reporting) CIK: 0001836816 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38067 | Film No.: 251186875